Insights

Choate Receives Significant Accolades in 2024 IAM Patent 1000

Choate has been recognized by IAM Patent 1000: The World’s Leading Patent Professionals 2024.

Eric Marandett and Anita Spieth Speaking at BIO IPCC 2023

Eric Marandett will moderate and Anita Spieth will be a panelist discussing, "Patent Implications of the Inflation Reduction Act" at this year's BIO IP Counsels Committee (BIO IPCC) Conference.

Anita Spieth Speaking at ACI’s 9th Annual Paragraph IV Disputes Master Symposium

Anita Spieth will be a panelist at the ACI’s 9th Annual Paragraph IV Disputes Master Symposium on Tuesday, October 24th discussing, "Patents, Drug Pricing, and Price Controls: Understanding the Inflation Reduction Act (IRA) Will Impact The Value of Pharmaceutical IP."

Choate Obtains Federal Circuit Affirmation of PTAB Decision

Choate and Anita Spieth are noted in Law360’s article, “Individual Inventors Face Rough Day At Federal Circuit,” regarding a three-judge panel’s non-precedential opinion in Shamoon v. Resideo Technologies Inc. The Federal Circuit upheld the PTAB's decision to invalidate an inventor’s patent claims related to wireless communications.

Anita Spieth Moderates at 2022 BIO Intellectual Property Counsels Committee Conference

Anita Spieth will moderate a panel on the current state of biosimilar litigation at the 2022 BIO Intellectual Property Counsels Committee Conference on Tuesday, November 15th at 9:00 a.m.

Anita Spieth named co-chair of Intellectual Property Litigation

Anita Spieth joins Eric Marandett and Michael Bunis leading Choate’s Intellectual Property Litigation practice, overseeing the group’s growth strategy, client experience, and talent development initiatives.

Choate Attorneys and Practice Groups Receive High Rankings in the 2022 Legal 500

The Legal 500 2022 recognized 31 Choate attorneys in their respective fields and 14 practice areas, with education and middle-market M&A receiving Tier 1 rankings.

FDA Issues Continued Guidance on Biosimilar Development and the BPCIA

The Biologics Price Competition and Innovation Act (“BPCIA”) created an abbreviated licensure pathway for biological products shown to be biosimilar to or interchangeable with an FDA-licensed biological reference product.  

Choate Ranks Highly in The Legal 500 2021 Guide

The Legal 500 2021 recognized 31 Choate attorneys in their respective fields and 11 practice areas, with education and middle-market M&A receiving Tier 1 rankings.